TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹905 Cr | ₹186 Cr | ₹-134 Cr | ₹750 Cr | ₹630 Cr |
What is the latest Net Current Assets ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹905 Cr |
| Mar2024 | ₹186 Cr |
| Mar2023 | ₹-134 Cr |
| Mar2022 | ₹750 Cr |
| Mar2021 | ₹630 Cr |
How is Net Current Assets of TORRENT PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹905 Cr | 386.16 | |
| Mar2024 | ₹186 Cr | Positive | |
| Mar2023 | ₹-134 Cr | Negative | |
| Mar2022 | ₹750 Cr | 19.05 | |
| Mar2021 | ₹630 Cr | - | |
Compare Net Current Assets of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹135,615.5 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
| MANKIND PHARMA | ₹83,352.1 Cr | -1% | -10.1% | -18.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -6.1% |
-8.3% |
23.7% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses